Vimarsana
Biggest News Aggregation in the World

Page 7 - Oral Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oral Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oral Solution Today - Breaking & Trending Today

U.S. Crude Oil Inventories Unexpectedly Pull Back Sharply - Vimarsana News

U.S. Crude Oil Inventories Unexpectedly Pull Back Sharply

Crude oil inventories in the U.S. unexpectedly pulled back sharply in the week ended April 19th, according to a report released by the Energy Information Administration on Wednesday.

Dr. Reddy's Issues Voluntary Nationwide Recall of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg Due to Sub-Potency - Vimarsana News

Dr. Reddy's Issues Voluntary Nationwide Recall of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg Due to Sub-Potency

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced that it is voluntarily recalling six (6) lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer leve

Source: fda.gov
Dr Reddy Laboratories : . Reddy's issues voluntary nationwide recall of Sapropterin Dihyochloride Powder for Oral Solution 100 mg due to Sub-potency - Form 6-K - Vimarsana News

Dr Reddy Laboratories : . Reddy's issues voluntary nationwide recall of Sapropterin Dihyochloride Powder for Oral Solution 100 mg due to Sub-potency - Form 6-K

Dr. Reddy's issues voluntary nationwide recall of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg due to Sub-potency FOR IMMEDIATE RELEASE Hyderabad...

Upsher-Smith previews expansion of rare disease portfolio at 2024 AAN annual meeting - Vimarsana News

Upsher-Smith previews expansion of rare disease portfolio at 2024 AAN annual meeting

Upsher-Smith has broadened its offerings to include Vigadrone (vigabatrin) Tablets, 500 mg. Torpenz Tablets, a branded-generic everolimus tablet, will soon be available to prescribers and patients.

UPSHER-SMITH PREVIEWS EXPANSION OF ITS RARE DISEASE PORTFOLIO AT 2024 AAN ANNUAL MEETING - Vimarsana News

UPSHER-SMITH PREVIEWS EXPANSION OF ITS RARE DISEASE PORTFOLIO AT 2024 AAN ANNUAL MEETING

/PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be participating in the 2024 American Academy of Neurology (AAN)...